| 摘要 |
<p>The present invention relates to novel 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds, pharmaceutical compositions containing these compounds, and their use in treating allergic and inflammatory diseases and for inhibiting the production of Tumor Necrosis Factor (TNF).</p> |
